Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 02 - 08 tags : Disease save search
Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium™
Published: 2021-02-08 (Crawled : 21:03) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: 3.31%
H: 7.89%
C: 0.18%
disease gene therapies therapy aav9 gene therapy
Amicus Therapeutics Presents Positive Preclinical Fabry Disease Gene Therapy Data at the 17th Annual WORLDSymposium™ 2021
Published: 2021-02-08 (Crawled : 20:00) - globenewswire.com
FOLD 4 | $10.52 -1.77% -1.81% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.7%
C: -3.95%
gene therapy positive therapy disease gene therapies preclinical pre-clinical
Amicus Therapeutics Announces Positive Initial Clinical Data for CLN3 Batten Disease Gene Therapy at the 17th Annual WORLDSymposium™ 2021
Published: 2021-02-08 (Crawled : 20:00) - globenewswire.com
FOLD 4 | $10.52 -1.77% -1.81% 1.6M
|
Health Technology
|
| O: 0.76%
H: 0.7%
C: -3.95%
gene therapy positive therapy disease gene therapies
Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease
Published: 2021-02-08 (Crawled : 13:31) - globenewswire.com
SAVA M | $20.75 0.97% 0.96% 480K
|
Health Technology
|
| O: 16.32%
H: 32.41%
C: 16.43%
disease alzheimer alzheimer’s milestone alzheimer's disease program alzheimer's
Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease
Published: 2021-02-08 (Crawled : 13:26) - globenewswire.com
UBX | $1.48 -0.67% -0.68% 82K
|
Health Technology
|
| O: 7.82%
H: 0.28%
C: -0.83%
eye disease disease eye
Sigilon Therapeutics Announces Preclinical Data in Multiple Lysosomal Diseases at the 17th Annual WORLDSymposium™
Published: 2021-02-08 (Crawled : 13:25) - globenewswire.com
SGTX | $22.47 -2.56% 0.0% 0
|
Health Technology
|
| O: 0.61%
H: 15.22%
C: 12.25%
disease preclinical pre-clinical
AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson’s Disease
Published: 2021-02-08 (Crawled : 12:25) - globenewswire.com
ACIU | $2.33 -2.1% -2.15% 320K
|
Health Technology
|
| O: -3.21%
H: 13.43%
C: 12.11%
disease parkinson diagnostic
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options
Published: 2021-02-08 (Crawled : 12:25) - globenewswire.com
PASG | News | $1.27 3.25% 3.15% 39K
|
Health Technology
|
| O: 0.97%
H: 6.7%
C: -4.96%
gene therapy therapy disease treatment fda fda clearance gene therapies rare
uniQure Announces Positive Recommendation from Data Safety Monitoring Board of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
Published: 2021-02-08 (Crawled : 12:25) - globenewswire.com
QURE | $4.57 -3.79% -3.94% 640K
|
Health Technology
|
| O: 6.75%
H: 2.6%
C: 0.83%
positive huntington disease treatment trial huntington’s disease
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.